Mpox Virus and its ocular surface manifestations

The Mpox virus (MPXV) is the causative agent of human Mpox disease – a debilitating rash illness similar to smallpox. Although Clade I MPXV has remained endemic to West and Central Africa, Clade II MPXV has been responsible for many outbreaks worldwide. The most recent outbreak in 2022 resulted from...

Full description

Saved in:
Bibliographic Details
Published in:The ocular surface 2024-10, Vol.34, p.108-121
Main Authors: Chakravarty, Nikhil, Hemani, Darshi, Paravastu, Ramya, Ahmad, Zeeshan, Palani, Sankara Naynar, Arumugaswami, Vaithilingaraja, Kumar, Ashok
Format: Article
Language:English
Subjects:
Cidofovir
Eye Infections, Viral - epidemiology
Eye Infections, Viral - virology
Humans
Monkeypox
Mpox
Mpox (monkeypox) - epidemiology
Mpox (monkeypox) - virology
Ocular
Ophthalmic
Orthopoxvirus
Orthopoxvirus - genetics
Tecovirimat (TPOXX)
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Mpox virus (MPXV) is the causative agent of human Mpox disease – a debilitating rash illness similar to smallpox. Although Clade I MPXV has remained endemic to West and Central Africa, Clade II MPXV has been responsible for many outbreaks worldwide. The most recent outbreak in 2022 resulted from the rapid spread of a new clade of MPXV, classified into Clade IIb – a distinct lineage from the previously circulating viral strains. The rapid spread and increased severity of Mpox disease by the Clade IIb strain have raised the serious public health imperative of better understanding the host and viral determinants during MPXV infection. In addition to typical skin rashes, including in the periorbital area, MPXV causes moderate to severe ophthalmic manifestations – most commonly, ocular surface complications (e.g., keratitis, conjunctivitis, blepharitis). While ocular manifestations of Clade I Mpox within the Congo basin have been well-reported, global incidence trends of ocular Mpox cases by Clade IIb are still emerging. Given the demonstrated ability of all MPXV strains to auto-inoculate ocular tissue, alongside the enhanced transmissibility of the Clade IIb virus, there is an urgent need to elucidate the mechanisms by which MPXV causes ocular anomalies. In this review, we discuss the viral and genomic structures of MPXV, the epidemiology, and pathology of systemic and ocular Mpox, as well as potential prophylactic and therapeutic interventions.
ISSN:1542-0124
1937-5913
1937-5913
DOI:10.1016/j.jtos.2024.07.001